RASRx's Corporate Minority Round

RASRx raised a round of funding on January 06, 2016. Investors include CureDuchenne.

RASRx is a start-up company dedicated to developing therapies for rare diseases. The company is developing an oral therapy that has shown positive effects on muscle function in a mdx mouse model of Du…

Articles about RASRx's Corporate Minority Round: